Sunitinib

Sunitinib is used in the treatment of kidney cancer and gastrointestinal stromal tumour.

Sunitinib is an anti-cancer medication. It works by binding and blocking certain cell surface protein (tyrosine kinase) responsible for the propagation of cancer growth. It also restricts the growth of new blood vessels within the tumor. This is how it prevents the proliferation of malignant cancers.

Nausea, Vomiting, Weakness, Rash, Abdominal pain, Fatigue, Fever, Bleeding, High blood pressure, Diarrhea, Constipation, Back pain, Weight loss, Cough, Taste change, Breathlessness, Decreased level of thyroid hormones, Muscle pain, Insomnia (difficulty in sleeping), Hair loss, Decreased appetite, Flatulence, Mucositis, Skin discoloration, Hand-foot-and-mouth disease, Change in color of hair, Decreased white blood cell count (neutrophils), Decreased white blood cell count (lymphocytes), Increased aspartate aminotransferase, Increased alanine aminotransferase, Increased bilirubin in the blood, Increased lipase in the blood, Increased creatinine level in blood, Decreased in left ventricular ejection fraction, Decreased potassium level in blood, Increased sodium level in blood, Dryness in mouth, Mouth pain, Tongue pain, Piles, Pain in extremity, Nasopharyngitis (inflammation of the throat and nasal passages)